UPDATE: 3SBio Enters 'Go Private' Deal, Consideration Raised to $2.3857/Share or $16.70/ADS

3SBio Inc. (NASDAQ: SSRX)("3SBio" or the "Company"), a leading China-based biotechnology companyfocused on researching, developing, manufacturing and marketingbiopharmaceutical products, today announced that it has entered into anamendment (the "Amendment") to its previously announced agreement and plan ofmerger dated as of February 8, 2013, by and among Decade Sunshine Limited("Parent"), Decade Sunshine Merger Sub ("Merger Sub") and the Company (the"Merger Agreement", and the Merger Agreement as so amended, the "AmendedMerger Agreement"), pursuant to which Merger Sub will be merged with and intothe Company, with the Company surviving the merger as a wholly-ownedsubsidiary of Parent (the "Merger").  The Amendment follows the revised "goingprivate" proposal from Dr. Jing Lou, the Company's chairman and chiefexecutive officer ("Dr. Lou"), and CPEChina Fund, L.P., a China-focusedprivate equity fund associated with CITIC Private Equity Funds Management Co.Ltd. ("CITIC PE", and together with Dr. Lou, the "Buyer Consortium") toincrease the merger consideration under the Merger Agreement that was receivedand announced by the Company on April 22, 2013.  If completed, the Mergerwould result in the Company becoming a privately-held company and its AmericanDepository Shares ("ADSs") would no longer be listed on the NASDAQ GlobalMarket ("NASDAQ").Pursuant to the Amendment, the merger consideration payable to holders ofordinary shares, par value $0.0001 per share, of the Company (the "Shares"),and holders of ADSs, under the Merger Agreement is increased from $2.20 perShare, or $15.40 per ADS, to $2.3857 per Share, or $16.70 per ADS.  Theincrease in the merger consideration represents an approximately 8.4% premiumto the original merger consideration under the Merger Agreement, 9.9% premiumto the closing price of the ADSs on April 19, 2013, the last trading day priorto the Company's announcement on April 22, 2013 that it had received therevised "going private" proposal from the Buyer Consortium , and 44.1% premiumto the closing price of the ADSs on September 11, 2012, the last trading dayprior to the Company's announcement on September 12, 2012 that it had receivedthe original "going private" proposal from the Buyer Consortium.    Parent intends to finance the increase in the merger consideration through acombination of additional convertible note financing from CITIC PE andadditional cash in the Company.